Can Brain Scans Help Predict How Parkinson’s Will Progress?

One of the toughest things about Parkinson’s disease is its unpredictability. Two people may be diagnosed around the same time, but their symptoms can develop very differently. Being able to forecast who is likely to get worse more quickly would make a big difference — for doctors planning treatment, for clinical trials testing new drugs, and for people living with Parkinson’s who want to prepare for the future. A team of researchers in Sweden has taken a step in that direction using a brain scanning technique called magnetoencephalography (MEG). This scan measures the brain’s electrical activity, picking up tiny magnetic fields that neurons give off when they fire. The study followed 27 people with Parkinson’s and 30 healthy individuals over about four years, looking closely at how their brain signals changed and how that related to the progression of motor symptoms like stiffness (rigidity) and slowness (bradykinesia). The researchers weren’t just looking at the usual brain wave frequencies (like beta, alpha, and theta rhythms). They also focused on what’s called the aperiodic component of brain activity — basically the “background noise” that sits underneath the obvious rhythms. It turns out this background signal may carry a lot of useful information. Here’s what they found: People with Parkinson’s who developed more rigidity over time also showed a steepening of this background slope in the sensorimotor area of the brain — the region that controls movement. An increase in the background signal’s “offset” was linked to worsening slowness of movement. At the start of the study, people with Parkinson’s had higher levels of beta activity in certain brain regions compared to healthy controls, and this seemed to be linked to less severe slowness. But over time, in people whose bradykinesia worsened, this relationship weakened, suggesting that the initial higher beta activity might have been the brain’s way of compensating — a mechanism that eventually broke down. Using all these features, the team built a statistical model to see if baseline brain activity could predict future symptom progression. When tested on a separate group of 18 people with Parkinson’s, the model was able to explain about 20% of the variability in motor progression. The strongest predictors came from the aperiodic features, not the traditional oscillations. In plain language, the study suggests that changes in the brain’s background activity — which until recently many researchers ignored — may be a key marker of how Parkinson’s symptoms progress over time. This is early research, and it won’t be used in clinics tomorrow. But it shows promise for a future where a simple resting brain scan could help predict the course of Parkinson’s. That could help doctors tailor treatments more precisely, and it could also help clinical trials by identifying which patients are most likely to worsen quickly, making it easier to test whether new therapies are slowing the disease. For now, it’s another reminder that Parkinson’s is not just about dopamine or tremors — it’s a whole-brain condition, and modern tools are giving us new ways to understand its complexity.